Latest News

  • DNAe Brings Next Generation Sequencing To The Clinical Point-Of-Need With Diagnostic Tests Pipeline

    Diagnostics World Brief | DNAe announced that its CBO, Nick McCooke, presented an update on its first product, the LiDia bloodstream infections (BSI) test, and outlined DNAe’s pipeline of genomic-based tests at BioCentury’s 24th Annual Newsmakers in the Biotech Industry.

    Sep 13, 2017
  • 2020 And Beyond: The Struggle To Stamp Out Neglected Tropical Diseases

    Diagnostics World | As the global community brings infection rates down, diagnostics could play a more pivotal role.

    Sep 12, 2017
  • Kevin Hrusovsky’s Vision For Diagnostics Future

    Diagnostics World Video | Kevin Hrusovsky, CEO at Quanterix, sees a handheld future for diagnostics. Breast cancer diagnostics at home, concussion diagnostics on the sidelines, Hrusovsky sees a future that is portable and delivers results in real time.

    Sep 11, 2017
  • Roche Blood Test Could Help “Personalize” Cancer Immunotherapy

    Reuters | A new blood test from Roche and Foundation Medicine has shown it can accurately measure the number of mutations within a tumor, potentially helping doctors predict which patients may respond best to some immunotherapies.

    Sep 8, 2017
  • The Return Of Individual Research Results: Through The Eyes Of Clinicians, Researchers, Participants

    Diagnostics World Contributed Commentary | In the field of biobanking, especially when broad consent is obtained, providing biospecimen-derived research results to participants is a complex and evolving issue. We must remember the context under which these results are generated and that the objectives and responsibilities in the research realm are not the same as in the clinical realm.

    Sep 7, 2017
  • Video: CVS Health Discusses The Future Of Point-Of-Care Testing

    Diagnostics World Video | Alex Sbordone, senior advisor, operations, MinuteClinic, CVS Health; and Andrea Vastis, senior manager, pharmacy produce development, patient care programs, CVS Health sit down with Diagnostics World editor Allison Proffitt to discuss point-of-care testing, patient perception, and getting payers on board.

    Sep 6, 2017
  • Is Saliva Test To Diagnose Concussions In English Rugby Worth A Spit?

    Forbes | If rugby and other sports need a cautionary tale about putting hype over science, they need only remember the disaster that was the biotech start-up Theranos and its promise of quick and easy blood testing.

    Sep 1, 2017
  • DNAstack, CareFirst, iCubate, And More: News From August 2017

    Diagnostics World | August featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including DNAstack, CareFirst, iCubate, and more.

    Aug 31, 2017
  • New Diagnostic Technology Is Key To Tackling Antimicrobial Resistance

    Diagnostics World Contributed Commentary | With the risk of anti-microbial resistance ratcheting up news agendas across the globe, there’s a growing awareness among the general public that we’re rapidly reverting to a time when a simple cut could prove deadly.

    Aug 29, 2017
  • Freenome Announces Series A Extension Led By Section 32

    Diagnostics World Brief | Freenome announced that it has raised an additional $7 million as an extension to its previously announced Series A funding, bringing the total to nearly $72 million. Proceeds from the Series A funding are being used to accelerate clinical trials, expand research, and bring the company’s disease screening products to market.

    Aug 28, 2017
  • Blood Test For Colitis Screening Using Infrared Technology Could Reduce Dependence On Colonoscopy

    Medical News Today | A fast, simple blood test for ulcerative colitis using infrared spectroscopy could provide a cheaper, less invasive alternative for screening compared to colonoscopy, which is now the predominant test, according to a study between the Department of Physics and Astronomy and the Institute for Biomedical Sciences at Georgia State University.

    Aug 28, 2017
  • Pharmacy Students Practice Point-Of-Care Disease Management

    Diagnostics World In the second annual Pharmacy Student Point-of-Care Disease Management Competition, held last week at the Next Generation Dx Summit*, pharmacy student Jacob Duncan from the University of Nebraska Medical Center, was awarded the grand prize for his assessment of a patient in a mock care situation.

    Aug 25, 2017
  • Dispatches From The Expo Floor

    Diagnostics World | At the Next Generation Dx Summit last week, over 100 exhibitors and sponsors shared new technologies, research updates, and their visions for the future of diagnostics. Diagnostics World toured the expo floor, talking with speakers and tech experts, gathering more perspective for what’s need next in diagnostics.

    Aug 24, 2017
  • Diagnostics In Review: 2017 Next Generation Dx Summit

    Diagnostics World | Some highlights from the session rooms at the 2017 Next Generation Diagnostic Summit, where over 1,000 diagnostics professionals converged to explore diagnostics technologies and challenges, including point-of-care diagnostics, clinical NGS, circulating tumor cells, biomarkers, coverage and reimbursement, and companion diagnostics.

    Aug 23, 2017
  • Washington Weighs In On Diagnostics

    Diagnostics World | Last week at the Next Generation Dx Summit, a bevy of Washington experts weighed in on policy and predictions for diagnostics in a keynote panel. Many of the panel’s concerns were the same; then they mentioned laboratory-developed tests.

    Aug 22, 2017
  • “Safer” Down's Syndrome Test To Be Introduced In Wales

    BBC News | A safer and more accurate test for Down's syndrome is to be introduced for pregnant mothers in Wales, the Welsh Government has announced. NIPT will be offered in 2018. The new blood test - while not offering a complete diagnosis - aims to better inform women of the risks of having a child with the genetic disorder.

    Aug 21, 2017
  • Inside The Lab Where Scientists Are Editing DNA In Human Embryos

    NPR.org | The Oregon Health & Science University have begun editing the DNA in human embryos to try to prevent genetic diseases, including in women undergoing in vitro fertilization.

    Aug 18, 2017